Cargando…
Appraisal of China's Response to the Outbreak of COVID-19 in Comparison With SARS
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2, was first reported in Wuhan, China, in December 2019 and has since become a pandemic. The COVID-19 containment measures were comparable to those used with severe acute respiratory syndrome (SARS), althoug...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292770/ https://www.ncbi.nlm.nih.gov/pubmed/34307279 http://dx.doi.org/10.3389/fpubh.2021.679540 |
_version_ | 1783724891086782464 |
---|---|
author | Li, Jiajia Li, Shixue Cao, Wuchun Wang, Zhongli Liang, Zhuohui Fu, Wenhao Zhao, Jinfeng |
author_facet | Li, Jiajia Li, Shixue Cao, Wuchun Wang, Zhongli Liang, Zhuohui Fu, Wenhao Zhao, Jinfeng |
author_sort | Li, Jiajia |
collection | PubMed |
description | Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2, was first reported in Wuhan, China, in December 2019 and has since become a pandemic. The COVID-19 containment measures were comparable to those used with severe acute respiratory syndrome (SARS), although these were stricter and more organized, and were initiated earlier and on a larger scale. Based on the lessons learned from SARS, the Chinese government acted aggressively in response to COVID-19, through a unified and effective commanding system, using law-based and science-driven strategies, and coordinated deployment of medical resources. Additionally, the application of high-tech measures, traditional Chinese medicine, and hierarchical medical systems also played an important role in control measures. Despite the remarkable performance, the initial delay in response suggests that the coordination between public health and medical services, reserve and coordination of emergency materials, and capacity for disease control and prevention need to be strengthened. |
format | Online Article Text |
id | pubmed-8292770 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82927702021-07-22 Appraisal of China's Response to the Outbreak of COVID-19 in Comparison With SARS Li, Jiajia Li, Shixue Cao, Wuchun Wang, Zhongli Liang, Zhuohui Fu, Wenhao Zhao, Jinfeng Front Public Health Public Health Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2, was first reported in Wuhan, China, in December 2019 and has since become a pandemic. The COVID-19 containment measures were comparable to those used with severe acute respiratory syndrome (SARS), although these were stricter and more organized, and were initiated earlier and on a larger scale. Based on the lessons learned from SARS, the Chinese government acted aggressively in response to COVID-19, through a unified and effective commanding system, using law-based and science-driven strategies, and coordinated deployment of medical resources. Additionally, the application of high-tech measures, traditional Chinese medicine, and hierarchical medical systems also played an important role in control measures. Despite the remarkable performance, the initial delay in response suggests that the coordination between public health and medical services, reserve and coordination of emergency materials, and capacity for disease control and prevention need to be strengthened. Frontiers Media S.A. 2021-07-07 /pmc/articles/PMC8292770/ /pubmed/34307279 http://dx.doi.org/10.3389/fpubh.2021.679540 Text en Copyright © 2021 Li, Li, Cao, Wang, Liang, Fu and Zhao. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Public Health Li, Jiajia Li, Shixue Cao, Wuchun Wang, Zhongli Liang, Zhuohui Fu, Wenhao Zhao, Jinfeng Appraisal of China's Response to the Outbreak of COVID-19 in Comparison With SARS |
title | Appraisal of China's Response to the Outbreak of COVID-19 in Comparison With SARS |
title_full | Appraisal of China's Response to the Outbreak of COVID-19 in Comparison With SARS |
title_fullStr | Appraisal of China's Response to the Outbreak of COVID-19 in Comparison With SARS |
title_full_unstemmed | Appraisal of China's Response to the Outbreak of COVID-19 in Comparison With SARS |
title_short | Appraisal of China's Response to the Outbreak of COVID-19 in Comparison With SARS |
title_sort | appraisal of china's response to the outbreak of covid-19 in comparison with sars |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292770/ https://www.ncbi.nlm.nih.gov/pubmed/34307279 http://dx.doi.org/10.3389/fpubh.2021.679540 |
work_keys_str_mv | AT lijiajia appraisalofchinasresponsetotheoutbreakofcovid19incomparisonwithsars AT lishixue appraisalofchinasresponsetotheoutbreakofcovid19incomparisonwithsars AT caowuchun appraisalofchinasresponsetotheoutbreakofcovid19incomparisonwithsars AT wangzhongli appraisalofchinasresponsetotheoutbreakofcovid19incomparisonwithsars AT liangzhuohui appraisalofchinasresponsetotheoutbreakofcovid19incomparisonwithsars AT fuwenhao appraisalofchinasresponsetotheoutbreakofcovid19incomparisonwithsars AT zhaojinfeng appraisalofchinasresponsetotheoutbreakofcovid19incomparisonwithsars |